Skip to Main Content

Paper Details

Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations.
Nat Cancer
25
2021
BM, CDK, Palbociclib, brain metastases, cyclin, cyclin-dependent kinase, palbociclib, patients
Author NameAffiliation
Priscilla K BrastianosMassachusetts General Hospital Cancer Center, Harvard Medical School
Nancy WangMassachusetts General Hospital Cancer Center, Harvard Medical School
Helen A ShihMassachusetts General Hospital Cancer Center, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital Cancer Center, Harvard Medical School
Tracy T BatchelorMassachusetts General Hospital Cancer Center, Harvard Medical School
Anthony J IafrateMassachusetts General Hospital Cancer Center, Harvard Medical School
Sandro SantagataDana-Farber Cancer Institute, Harvard Medical School
Scott L CarterDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2